Elegant BioSciences is committed to discover the potential of biology for people who suffering from serious illnesses, such as age relative diseases, cancer by discovering development, manufacturing and delivering innovative human therapeutics. This approach begins by using tools in advanced human genetics to unravel the complexities of disease and understanding the fundamentals of human biology.
Our goal—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.
We are focusing on the area of high unmet medical need and leverages its expertise to strive for solutions that improve human health and dramatically improve the people’s lives. A biotechnology innovator since 2014, Elegant Biosciences has already grown to be one of world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a R&D pipeline of medicines with breakaway potential.
Our leaders
Introduction to R&D Team
Our R&D Team is composed of professionals and technical elites from
the fields of chemistry, pharmacology, biology and formulation.
1.A pharmaceutical research and development team with 30 years of experience in the development and management of chemical and biological targeted agents;
2.A seasoned team of medical and pathological professionals with a collective 40 years' worth of expertise in the fields of Western medicine and pathology;
3.A production technology team boasting 25 years of specialized experience and expertise in production process;
4.A professional team with 30 years of production quality management system and control:
5.Experienced US FDA regulatory certification and sound declaration team.
Five core members in the team with more than three decades of expertise in the pharmaceutical industry
